Cocrystal Pharma COCP

NASDAQ COCP

$1.15 -0.02 (-1.71%)

At close: Aug 21, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Asset Utilization Ratio (2011 - 2026)

Cocrystal Pharma (COCP) posted Asset Utilization Ratio of 0.21 for Q1 2026, up 453.54% sequentially from 0.04 in Q4 2020.

Cocrystal Pharma (COCP) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Cocrystal Pharma has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.21 in Q1 2026.

Quarterly Asset Utilization Ratio changed N/A year-over-year to 0.21 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.21 (changed N/A YoY) and the FY2020 annual result came in at 0.05, down 64.01% from the prior year.
Asset Utilization Ratio climbed to 0.21 in Q1 2026 per COCP's latest filing, from 0.04 in the prior quarter.
Over five years, Asset Utilization Ratio peaked at 0.21 in Q1 2026 and troughed at 0.21 in Q1 2026.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.38
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.90
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.13
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Cocrystal Pharma	15.65 Mn	13.33 Mn	-	0.22

Historic Data

Download Data

Date	Value
Jun 30, 2026	0.22
Mar 31, 2026	0.21
Dec 31, 2020	0.04
Sep 30, 2020	0.04
Jun 30, 2020	0.05
Mar 31, 2020	0.05
Dec 31, 2019	0.13
Sep 30, 2019	0.08
Jun 30, 2019	0.08
Mar 31, 2019	0.07
Jun 30, 2013	1.68
Mar 31, 2013	2.19
Dec 31, 2012	2.22
Sep 30, 2012	1.96
Jun 30, 2012	1.88
Mar 31, 2012	1.76
Dec 31, 2011	1.42
Sep 30, 2011	1.23

Cocrystal Pharma (COCP)

NASDAQ: COCP

$1.15 ▼ -0.02 (-1.71%)

Aug 21, 2026 · 4:00 PM EDT